Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: Proof of concept with dopamine D1/D3 heterodimer

ACS Chemical Biology

Volumn 10, Issue 2, 2015, Pages 466-474

  Hounsou, Candide ^a   Margathe, Jean François ^b   Oueslati, Nadia ^a   Belhocine, Abderazak ^a   Dupuis, Elodie ^c   Thomas, Cécile ^b   Mann, André ^b   Ilien, Brigitte ^b   Rognan, Didier ^b   Trinquet, Eric ^c   Hibert, Marcel ^b   Pin, Jean Philippe ^a   Bonnet, Dominique ^b   Durroux, Thierry ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Cisbio Bioassays   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BP 897; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HETERODIMER; OLIGOMER; FLUORESCENT DYE; PIPERAZINE DERIVATIVE; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN STRUCTURE; RECEPTOR BINDING; SYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; PROCEDURES; PROTEIN CONFORMATION; STAINING;

FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT DYES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PIPERAZINES; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D3; STAINING AND LABELING;

EID: 84923357172     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb5007568     Document Type: Article

References (40)

1. Overington, J. P., Al-Lazikani, B., and Hopkins, A. L. (2006) How many drug targets are there? Nat. Rev. Drug Discovery 5, 993-996
2. Jordan, B. A. and Devi, L. A. (1999) G-protein-coupled receptor heterodimerization modulates receptor function Nature 399, 697-700
3. Ferre, S., Casado, V., Devi, L. A., Filizola, M., Jockers, R., Lohse, M. J., Milligan, G., Pin, J. P., and Guitart, X. (2014) G protein-coupled receptor oligomerization revisited: Functional and pharmacological perspectives Pharmacol. Rev. 66, 413-434
4. Fiorentini, C., Busi, C., Gorruso, E., Gotti, C., Spano, P., and Missale, C. (2008) Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization Mol. Pharmacol. 74, 59-69
5. Albizu, L., Cottet, M., Kralikova, M., Stoev, S., Seyer, R., Brabet, I., Roux, T., Bazin, H., Bourrier, E., Lamarque, L., Breton, C., Rives, M. L., Newman, A., Javitch, J., Trinquet, E., Manning, M., Pin, J. P., Mouillac, B., and Durroux, T. (2010) Time-resolved FRET between GPCR ligands reveals oligomers in native tissues Nat. Chem. Biol. 6, 587-594
6. Albizu, L., Holloway, T., Gonzalez-Maeso, J., and Sealfon, S. C. (2011) Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors Neuropharmacology 61, 770-777
7. Gonzalez-Maeso, J., Ang, R. L., Yuen, T., Chan, P., Weisstaub, N. V., Lopez-Gimenez, J. F., Zhou, M., Okawa, Y., Callado, L. F., Milligan, G., Gingrich, J. A., Filizola, M., Meana, J. J., and Sealfon, S. C. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452, 93-97
8. Rivero-Muller, A., Chou, Y. Y., Ji, I., Lajic, S., Hanyaloglu, A. C., Jonas, K., Rahman, N., Ji, T. H., and Huhtaniemi, I. (2010) Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation Proc. Natl. Acad. Sci. U.S.A. 107, 2319-2324
9. Vassart, G. (2010) An in vivo demonstration of functional G protein-coupled receptor dimers Proc. Natl. Acad. Sci. U.S.A. 107, 1819-1820
10. Trinquet, E., Zwier, J., Mathis, G., Pin, J.-P., and Durroux, T. Method for predetermining the binding of a given compound to a membrane receptor. Patent WO/2011/018586.
11. Albizu, L., Teppaz, G., Seyer, R., Bazin, H., Ansanay, H., Manning, M., Mouillac, B., and Durroux, T. (2007) Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands J. Med. Chem. 50, 4976-4985
12. Leyris, J. P., Roux, T., Trinquet, E., Verdie, P., Fehrentz, J. A., Oueslati, N., Douzon, S., Bourrier, E., Lamarque, L., Gagne, D., Galleyrand, J. C., MKadmi, C., Martinez, J., Mary, S., Baneres, J. L., and Marie, J. (2011) Homogeneous time-resolved fluorescence-based assay to screen for ligands targeting the growth hormone secretagogue receptor type 1a Anal. Biochem. 408, 253-262
13. Loison, S., Cottet, M., Orcel, H., Adihou, H., Rahmeh, R., Lamarque, L., Trinquet, E., Kellenberger, E., Hibert, M., Durroux, T., Mouillac, B., and Bonnet, D. (2012) Selective fluorescent nonpeptidic antagonists for vasopressin V(2) GPCR: Application to ligand screening and oligomerization assays J. Med. Chem. 55, 8588-8602
14. Zwier, J. M., Roux, T., Cottet, M., Durroux, T., Douzon, S., Bdioui, S., Gregor, N., Bourrier, E., Oueslati, N., Nicolas, L., Tinel, N., Boisseau, C., Yverneau, P., Charrier-Savournin, F., Fink, M., and Trinquet, E. (2010) A fluorescent ligand-binding alternative using Tag-lite(R) technology J. Biomol. Screening 15, 1248-1259
15. Albizu, L., Balestre, M. N., Breton, C., Pin, J. P., Manning, M., Mouillac, B., Barberis, C., and Durroux, T. (2006) Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding Mol. Pharmacol. 70, 1783-1791
16. Maurel, D., Comps-Agrar, L., Brock, C., Rives, M. L., Bourrier, E., Ayoub, M. A., Bazin, H., Tinel, N., Durroux, T., Prezeau, L., Trinquet, E., and Pin, J. P. (2008) Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: Application to GPCR oligomerization Nat. Methods 5, 561-567
17. Beaulieu, J. M. and Gainetdinov, R. R. (2011) The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 63, 182-217
18. Girault, J. A. and Greengard, P. (2014) The neurobiology of the dopamine signaling Arch. Neurol. 61, 641-644
19. Marcellino, D., Ferre, S., Casado, V., Cortes, A., Le Foll, B., Mazzola, C., Drago, F., Saur, O., Stark, H., Soriano, A., Barnes, C., Goldberg, S. R., Lluis, C., Fuxe, K., and Franco, R. (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum J. Biol. Chem. 283, 26016-26025
20. Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J. C., Everitt, B. J., and Sokoloff, P. (1999) Selective inhibition of cocaine-seeking behavior by a partial dopamine D3 receptor agonist Nature 400, 371-375
21. Chien, E. Y., Liu, W., Zhao, Q., Katritch, V., Han, G. W., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., and Stevens, R. C. (2010) Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist Science 330, 1091-1095
22. Michino, M., Donthamsetti, P., Beuming, T., Banala, A., Duan, L., Roux, T., Han, Y., Trinquet, E., Newman, A. H., Javitch, J. A., and Shi, L. (2013) A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine d2 and d3 receptors Mol. Pharmacol. 84, 854-864
23. Daval, S. B., Kellenberger, E., Bonnet, D., Utard, V., Galzi, J. L., and Ilien, B. (2013) Exploration of the orthosteric/allosteric interface in human M1Muscarinic receptors by bitopic fluorescent ligands Mol. Pharmacol. 84, 71-85
24. Bouzide, A. and Sauve, G. (1997) Highly selective silver(I) oxide mediated monoprotection of symmetrical diols Tetrahedron Lett. 38, 5945-5948
25. Xu, J., Corneillie, T. M., Moore, E. G., Law, G. L., Butlin, N. G., and Raymond, K. N. (2011) Octadentate cages of Tb(III) 2-hydroxyisophthalamides: a new standard for luminescent lanthanide labels J. Am. Chem. Soc. 133, 19900-19910
26. Gronemeyer, T., Chidley, C., Juillerat, A., Heinis, C., and Johnsson, K. (2006) Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling Protein Eng., Des. Sel. 19, 309-316
27. Juillerat, A., Gronemeyer, T., Keppler, A., Gendreizig, S., Pick, H., Vogel, H., and Johnsson, K. (2003) Directed evolution of O6-alkylguanine-DNA alkyltransferase for efficient labeling of fusion proteins with small molecules in vivo Chem. Biol. 10, 313-317
28. Juillerat, A., Heinis, C., Sielaff, I., Barnikow, J., Jaccard, H., Kunz, B., Terskikh, A., and Johnsson, K. (2005) Engineering substrate specificity of O6-alkylguanine-DNA alkyltransferase for specific protein labeling in living cells ChemBioChem 6, 1263-1269
29. Keppler, A., Gendreizig, S., Gronemeyer, T., Pick, H., Vogel, H., and Johnsson, K. (2003) A general method for the covalent labeling of fusion proteins with small molecules in vivo Nat. Biotechnol. 21, 86-89
30. Keppler, A., Pick, H., Arrivoli, C., Vogel, H., and Johnsson, K. (2004) Labeling of fusion proteins with synthetic fluorophores in live cells Proc. Natl. Acad. Sci. U.S.A. 101, 9955-9959
31. Tahtaoui, C., Parrot, I., Klotz, P., Guillier, F., Galzi, J. L., Hibert, M., and Ilien, B. (2004) Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor J. Med. Chem. 47, 4300-4315
32. Sadowski, J., Gasteiger, J., and Klebe, G. (1994) Comparison of automatic three-dimensional model builders using 639 X-ray structures J. Chem. Inf. Comput. Sci. 34, 1000-1008
33. Oueslati, N., Hounsou, C., Belhocine, A., Rodriguez, T., Dupuis, E., Zwier, J. M., Trinquet, E., Pin, J.-P., and Durroux, T. (2015) Time-resolved FRET strategy to screen GPCR ligands library in GPCR Screening Assays: Methods and Protocols (Martins, S. A. M. and Prazeres, M., Eds.) Springer Science, New York, in press.
34. Levesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., and Sokoloff, P. (1992) Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di- n -propyl-2-aminotetralin Proc. Natl. Acad. Sci. U.S.A. 89, 8155-8159
35. Freedman, S. B., Patel, S., Marwood, R., Emms, F., Seabrook, G. R., Knowles, M. R., and McAllister, G. (1994) Expression and pharmacological characterization of the human D3 dopamine receptor J. Pharmacol. Exp. Ther. 268, 417-426
36. Holmes, I. P., Blunt, R. J., Lorthioir, O. E., Blowers, S. M., Gribble, A., Payne, A. H., Stansfield, I. G., Wood, M., Woollard, P. M., Reavill, C., Howes, C. M., Micheli, F., Di Fabio, R., Donati, D., Terreni, S., Hamprecht, D., Arista, L., Worby, A., and Watson, S. P. (2010) The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure Bioorg. Med. Chem. Lett. 20, 2013-2016
37. Tiberi, M. and Caron, M. G. (1994) High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype J. Biol. Chem. 269, 27925-27931
38. Sunahara, R. K., Guan, H. C., ODowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H., and Niznik, H. B. (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 Nature 350, 614-619
39. Stierand, K., Maass, P. C., and Rarey, M. (2006) Molecular complexes at a glance: automated generation of two-dimensional complex diagrams Bioinformatics 22, 1710-1716
40. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108